ORGS
Price:
$0.495
Market Cap:
$2.56M
Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies. The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a portfolio of licensed POCare therapeutics, which are manufactured and prepared using automated, self-contained POCare technology within a cooperative network. Orgenesis primarily concentrates on autologous therapies, developing customized processes and systems for each treatment. These utilize a closed, automated processing methodology, validated for safe and compliant production directly at the patient's location, facilitating immediate therapeutic application. Established in 2008 as Business Out...[Read more]
Industry
Biotechnology
IPO Date
2012-03-13
Stock Exchange
OTC
Ticker
ORGS
According to Orgenesis Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -98.74% compared to the average of -1.59 of the last 4 quarters.
The mean historical PE Ratio of Orgenesis Inc. over the last ten years is -34.44. The current -0.02 PE Ratio has changed -94.19% with respect to the historical average. Over the past ten years (40 quarters), ORGS's PE Ratio was at its highest in in the February 2016 quarter at 378.13. The PE Ratio was at its lowest in in the March 2021 quarter at -1582.48.
Average
-34.44
Median
-39.99
Minimum
-58.06
Maximum
-2.62
Discovering the peaks and valleys of Orgenesis Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 286.57%
Maximum Annual PE Ratio = -2.62
Minimum Annual Increase = -92.03%
Minimum Annual PE Ratio = -58.06
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -2.62 | -92.03% |
| 2022 | -32.87 | -15.09% |
| 2021 | -38.71 | 286.57% |
| 2020 | -10.01 | -64.82% |
| 2019 | -28.47 | -35.22% |
| 2018 | -43.94 | -2.53% |
| 2017 | -45.08 | 3.94% |
| 2016 | -43.38 | 5.09% |
| 2015 | -41.28 | -28.91% |
| 2014 | -58.06 | -14.85% |
The current PE Ratio of Orgenesis Inc. (ORGS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-24.73
5-year avg
-22.54
10-year avg
-34.44
Orgenesis Inc.’s PE Ratio is less than SQZ Biotechnologies Company (-0.01), greater than Helix BioMedix, Inc. (-0.73), greater than Bio-Path Holdings, Inc. (-0.06), greater than Emmaus Life Sciences, Inc. (-0.09), less than Indocan Resources Inc. (0), greater than Neutra Corp. (-43.84), greater than Paion AG (-4.44), less than Viropro Inc. (-0.00), greater than Unity Biotechnology, Inc. (-0.21), less than Next Generation Management Corp. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.01 | $707.79K | |
| -0.73 | $402.23K | |
| -0.06 | $373.69K | |
| -0.09 | $722.94K | |
| 0 | $74.08K | |
| -43.84 | $291.79K | |
| -4.44 | $75.26K | |
| -0.00 | $25.40K | |
| -0.21 | $965.60K | |
| -0.00 | $25.71K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orgenesis Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orgenesis Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Orgenesis Inc.'s PE Ratio?
How is the PE Ratio calculated for Orgenesis Inc. (ORGS)?
What is the highest PE Ratio for Orgenesis Inc. (ORGS)?
What is the 3-year average PE Ratio for Orgenesis Inc. (ORGS)?
What is the 5-year average PE Ratio for Orgenesis Inc. (ORGS)?
How does the current PE Ratio for Orgenesis Inc. (ORGS) compare to its historical average?